ProPhase Labs Correlations
| PRPH Stock | USD 0.16 0.01 5.88% |
The current 90-days correlation between ProPhase Labs and Co Diagnostics is -0.1 (i.e., Good diversification). The correlation of ProPhase Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
ProPhase Labs Correlation With Market
Pay attention - limited upside
The correlation between ProPhase Labs and DJI is -0.86 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ProPhase Labs and DJI in the same portfolio, assuming nothing else is changed.
Moving together with ProPhase Stock
Moving against ProPhase Stock
| 0.93 | TEV | Teva Pharmaceutical | PairCorr |
| 0.93 | C43 | Cosmo Pharmaceuticals | PairCorr |
| 0.92 | RO | Roche Holding AG | PairCorr |
| 0.91 | RHO6 | Roche Holding | PairCorr |
| 0.87 | MRK | Merck KGaA | PairCorr |
| 0.87 | BRM | Bristol Myers Squibb | PairCorr |
| 0.82 | CVG | CSPC Pharmaceutical | PairCorr |
| 0.81 | LDZU | ASPEN PHARUNADR 1 | PairCorr |
| 0.8 | VTRS | Viatris Aggressive Push | PairCorr |
| 0.76 | DYF1 | Dynavax Technologies Earnings Call Tomorrow | PairCorr |
| 0.74 | ELAN | Elanco Animal Health Earnings Call This Week | PairCorr |
| 0.72 | SFZN | Siegfried Holding Earnings Call This Week | PairCorr |
| 0.67 | VTYX | Ventyx Biosciences | PairCorr |
| 0.57 | VRCA | Verrica Pharmaceuticals | PairCorr |
| 0.46 | H6D | Haleon PLC Earnings Call This Week | PairCorr |
| 0.46 | R9U2 | Green Thumb Industries Earnings Call This Week | PairCorr |
| 0.44 | PFE | Pfizer Inc CDR | PairCorr |
| 0.43 | TED | TerrAscend Corp | PairCorr |
| 0.42 | 7XP | Organon | PairCorr |
| 0.38 | ELVN | Enliven Therapeutics | PairCorr |
| 0.33 | PFE | Pfizer Inc | PairCorr |
| 0.93 | HHU | ALLERGY THER PLC | PairCorr |
| 0.89 | EVOK | Evoke Pharma | PairCorr |
| 0.89 | BMY | Bristol Myers Squibb | PairCorr |
| 0.82 | YPHA | ASTELLAS PHARMA UNSPADR | PairCorr |
| 0.82 | LDZA | Aspen Pharmacare Holdings | PairCorr |
| 0.81 | 6CW | CIG WIRELESS | PairCorr |
| 0.77 | 2DT | Amneal Pharmaceuticals | PairCorr |
| 0.73 | JNJ | Johnson Johnson | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ProPhase Stock performing well and ProPhase Labs Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ProPhase Labs' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AYTU | 2.72 | 0.06 | 0.01 | 0.12 | 3.66 | 4.69 | 16.84 | |||
| TXMD | 4.86 | 0.66 | 0.10 | 0.43 | 6.31 | 12.11 | 43.44 | |||
| ALUR | 5.78 | (0.37) | 0.00 | 1.76 | 0.00 | 16.54 | 40.95 | |||
| ERNA | 5.56 | (1.85) | 0.00 | 1.97 | 0.00 | 12.10 | 59.74 | |||
| BFRI | 3.53 | (0.28) | 0.00 | (0.07) | 0.00 | 6.76 | 34.13 | |||
| ADAP | 12.64 | 0.58 | 0.03 | 2.31 | 15.04 | 22.82 | 168.52 | |||
| AEMD | 5.53 | (0.85) | 0.00 | (1.59) | 0.00 | 10.51 | 38.52 | |||
| CODX | 5.96 | (1.66) | 0.00 | (0.56) | 0.00 | 9.88 | 75.41 | |||
| LNAI | 6.55 | 0.02 | 0.00 | 0.02 | 0.00 | 19.44 | 52.90 | |||
| SBFM | 2.03 | (0.65) | 0.00 | (0.41) | 0.00 | 4.13 | 13.93 |
ProPhase Labs Corporate Management
| Billy White | Consultant | Profile | |
| Stu Hollenshead | Chief Officer | Profile | |
| Sergio Miralles | Executive Diagnostics | Profile | |
| Steven CPA | Chief Officer | Profile | |
| Kevin Quinn | Chief Genomics | Profile |